Table 1.
Statistics for BSL cohort.
| Male | Female | |
|---|---|---|
| Cohort size | 168 | 80 |
| CONSENT VARIABLES | ||
| Consent group ( phv00169057.v7.p2.c1 ) | ||
| General research use | 100.0% | 100.0% |
| No consent available | 0.0% | 0.0% |
| VARIABLES DEFINING COHORT | ||
| Male | 100.0% | 0.0% |
| Female | 0.0% | 100.0% |
| Type I/II diabetes (MHT1D or MHT2D) | ||
| Yes | 0.0% | 0.0% |
| No | 100.0% | 100.0% |
| Arthritis (MHARTHTS or MHRA) | ||
| Yes | 0.0% | 0.0% |
| No | 100.0% | 100.0% |
| Sepsis (MHSEPSIS) | ||
| Yes | 0.0% | 0.0% |
| No | 100.0% | 100.0% |
| HIV serology testing outcome (LBHIV1NT) | ||
| Positive | 0.0% | 0.0% |
| Negative | 94.6% | 97.5% |
| Not performed | 5.4% | 2.5% |
| DEMOGRAPHIC VARIABLES | ||
| Race (RACE) | ||
| Asian | 2.4% | 2.5% |
| African American/Black | 8.9% | 11.3% |
| White | 86.3% | 86.3% |
| Am. Indian/Alaska Native | 0.0% | 0.0% |
| Unknown | 2.4% | 0.0% |
| Age in years (AGE) | ||
| Mean | 50.9 | 52.0 |
| Standard deviation | 14.0 | 12.9 |
| BMI/HEIGHT/WEIGHT | ||
| Body mass index (BMI) | ||
| Mean | 27.2 | 27.3 |
| Standard deviation | 3.9 | 3.9 |
| Height in inches (HGHT) | ||
| Mean | 69.8 | 64.8 |
| Standard deviation | 3.1 | 2.8 |
| Weight in pounds (WGHT) | ||
| Mean | 188.8 | 163.6 |
| Standard deviation | 32.3 | 26.8 |
| POTENTIALLY CONFOUNDING CLINICAL VARIABLES | ||
| Lupus (MHLUPUS) | ||
| Yes | 0.0% | 0.0% |
| No | 100.0% | 100.0% |
| Cellulites (MHCLLULTS) | ||
| Yes | 0.0% | 0.0% |
| No | 100.0% | 100.0% |
| Scleroderma (MHSCLRDRM) | ||
| Yes | 0.0% | 0.0% |
| No | 100.0% | 100.0% |
| Sarcoidosis (MHSRCDSS) | ||
| Yes | 1.2% | 0.0% |
| No | 98.8% | 100.0% |
Sample Characteristics. Distribution of relevant demographic, anatomical, clinical and medical history variables for the male and female subcohorts in BSL show no significant differences for potentially confounding variables.